53 research outputs found

    Superconducting SET with tunable electromagnetic environment

    Full text link
    We have studied the environmental effect on superconducting single-electron transistors (S-SETs) by biasing S-SETs with arrays of small-capacitance dc SQUIDs, whose effective impedance can be varied in situ. As the zero-bias resistance of the arrays is increased, Coulomb blockade in the S-SET becomes sharper, and the gate-voltage dependence changes from e-periodic to 2e-periodic. The SQUID arrays could be used as on-chip noise filters.Comment: 2 pages, 3 embedded figures, submitted to LT23 proceedings. Error in Fig. 1 has been fixe

    XXZ chain with a boundary

    Get PDF
    The \XXZ spin chain with a boundary magnetic field hh is considered, using the vertex operator approach to diagonalize the Hamiltonian. We find explicit bosonic formulas for the two vacuum vectors with zero particle content. There are three distinct regions when h0h\geq0, in which the structure of the vacuum states is different. Excited states are given by the action of vertex operators on the vacuum states. We derive the boundary SS-matrix and present an integral formula for the correlation functions. The boundary magnetization exhibits boundary hysteresis. We also discuss the rational limit, the \XXX model.Comment: LaTeX 38 pages, 3 figures; epsf, epic, eepic. (Minor changes in text, and references added

    『リンディスファーン福音書』における本文文字について

    No full text

    プラーテンの詩と詩学(Ⅳ.オーデ)

    No full text

    腎細胞癌患者血清中の抗腫瘍抗体について

    Get PDF
    腎細胞癌19例の血清につき, ヒト腎細胞癌培養株OUR-10に対する抗腫瘍抗体を51Cr release法によるcomplement-dependent cytotoxicity (CDC)とantibody-dependent cell-mediated cytotoxicity (ADCC)の各assayで検討した.19例中8例に抗RCC抗体を認め, OUR-10に対する殺細胞性抗体は補体依存性抗体とし同定した.抗RCC抗体陽性患者では理学的にlow grade例に陽性率が有意に高く臨床的stageとの関係はなかったThe circulating anti-RCC cytotoxic antibodies of eighteen RCC patients, preoperatively, and one inoperable case were studied by 51Cr release CDC and ADCC assays, using the cultured human RCC cell line, OUR-10. Circulating cytotoxic anti-RCC antibodies were detected in eight patients as CDC antibodies. The patients with a low pathological grade had a significantly higher percentage (P less than 0.05) of positive antibody responses
    corecore